Epitel, Inc

Epitel, Inc has 2 AI-enabled medical devices on the FDA list. The first decision was on January 3, 2024 and the most recent on October 17, 2024 (REMI-AI Rapid Detection Module (REMI-AI RDM)). Its most common review panel is Neurology (2 devices).